267 related articles for article (PubMed ID: 23064660)
41. Molecular heterogeneity of splenic marginal zone lymphomas: analysis of mutations in the 5' non-coding region of the bcl-6 gene.
Mateo MS; Mollejo M; Villuendas R; Algara P; Sanchez-Beato M; Martínez P; Piris MA
Leukemia; 2001 Apr; 15(4):628-34. PubMed ID: 11368366
[TBL] [Abstract][Full Text] [Related]
42. Diagnostic and therapeutic splenectomy for splenic lymphomas: analysis of the National Cancer Data Base.
Fallah J; Olszewski AJ
Hematology; 2019 Dec; 24(1):378-386. PubMed ID: 30885066
[TBL] [Abstract][Full Text] [Related]
43. The morphologic spectrum of non-Hodgkin's lymphomas with BCL1/cyclin D1 gene rearrangements.
Swerdlow SH; Zukerberg LR; Yang WI; Harris NL; Williams ME
Am J Surg Pathol; 1996 May; 20(5):627-40. PubMed ID: 8619427
[TBL] [Abstract][Full Text] [Related]
44. [Pathologic characteristics of bone marrow for
CD5 positive small B cell lymphoma].
Peng S; Zhu F; You S; Gong M; Wen Z
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Apr; 41(4):374-9. PubMed ID: 27241147
[TBL] [Abstract][Full Text] [Related]
45. Immunohistochemical Expression of Lymphoid Enhancer Binding Factor 1 in CD5-Positive Marginal Zone, Lymphoplasmacytic, and Follicular Lymphomas.
Patel N; Durkin L; Bodo J; Hsi ED
Am J Clin Pathol; 2020 Apr; 153(5):646-655. PubMed ID: 31953940
[TBL] [Abstract][Full Text] [Related]
46. Splenic marginal zone lymphoma.
Dogan A; Isaacson PG
Semin Diagn Pathol; 2003 May; 20(2):121-7. PubMed ID: 12945935
[TBL] [Abstract][Full Text] [Related]
47. Distinctive clinical and histological features of Waldenström's macroglobulinemia and splenic marginal zone lymphoma.
Arcaini L; Varettoni M; Boveri E; Orlandi E; Rattotti S; Zibellini S; Merli M; Lucioni M; Rizzi S; Gotti M; Morello L; Pascutto C; Paulli M
Clin Lymphoma Myeloma Leuk; 2011 Feb; 11(1):103-5. PubMed ID: 21454204
[TBL] [Abstract][Full Text] [Related]
48. CD138 expression helps distinguishing Waldenström's macroglobulinemia (WM) from splenic marginal zone lymphoma (SMZL).
Kyrtsonis MC; Levidou G; Korkolopoulou P; Koulieris E; Bartzi V; Maltezas D; Pangalis GA; Kalpadakis C; Dimou M; Georgiou G; Vassilakopoulos TP; Angelopoulou MK; Salpeas V; Tsaftaridis P; Patsouris E; Panayiotidis P; Tzenou TK
Clin Lymphoma Myeloma Leuk; 2011 Feb; 11(1):99-102. PubMed ID: 21454203
[TBL] [Abstract][Full Text] [Related]
49. Hepatitis C virus infection and locally advanced splenic marginal zone lymphoma.
Szynglarewicz B; Matkowski R; Smorag Z; Forgacz J; Pudelko M; Kornafel J
Pathol Oncol Res; 2007; 13(4):382-4. PubMed ID: 18158578
[TBL] [Abstract][Full Text] [Related]
50. [Tumors of lymphoid and hematopoietic tissue of spleen: a clinicopathologic analysis of 53 cases].
Chen DB; Shen DH; Zhang H; Wang Y; Song QJ; Yang SM; Fang XZ
Zhonghua Bing Li Xue Za Zhi; 2017 Nov; 46(11):775-781. PubMed ID: 29136691
[No Abstract] [Full Text] [Related]
51. Splenic marginal zone lymphoma: from genetics to management.
Arcaini L; Rossi D; Paulli M
Blood; 2016 Apr; 127(17):2072-81. PubMed ID: 26989207
[TBL] [Abstract][Full Text] [Related]
52. Comparison of Myocyte Enhancer Factor 2B Versus Other Germinal Center-associated Antigens in the Differential Diagnosis of B-Cell Non-Hodgkin Lymphomas.
Moore EM; Swerdlow SH; Gibson SE
Am J Surg Pathol; 2018 Mar; 42(3):342-350. PubMed ID: 29309299
[TBL] [Abstract][Full Text] [Related]
53. [Marginal zone lymphomas: extranodal MALT type, nodal and splenic].
Dallenbach FE; Coupland SE; Stein H
Pathologe; 2000 Mar; 21(2):162-77. PubMed ID: 10840821
[TBL] [Abstract][Full Text] [Related]
54. Identification of MNDA as a new marker for nodal marginal zone lymphoma.
Kanellis G; Roncador G; Arribas A; Mollejo M; Montes-Moreno S; Maestre L; Campos-Martin Y; Ríos Gonzalez JL; Martinez-Torrecuadrada JL; Sanchez-Verde L; Pajares R; Cigudosa JC; Martin MC; Piris MA
Leukemia; 2009 Oct; 23(10):1847-57. PubMed ID: 19474799
[TBL] [Abstract][Full Text] [Related]
55. Absence of cyclin D1 protein expression in splenic marginal zone lymphoma.
Savilo E; Campo E; Mollejo M; Pinyol M; Piris MA; Zukerberg LR; Yang WI; Koelliker DD; Nguyen PL; Harris NL
Mod Pathol; 1998 Jul; 11(7):601-6. PubMed ID: 9688179
[TBL] [Abstract][Full Text] [Related]
56. Follicular lymphoma with involvement of the splenic marginal zone: a pitfall in the differential diagnosis of splenic marginal zone cell lymphoma.
Alkan S; Ross CW; Hanson CA; Schnitzer B
Hum Pathol; 1996 May; 27(5):503-6. PubMed ID: 8621189
[TBL] [Abstract][Full Text] [Related]
57. A comprehensive immunophenotypic marker analysis of hairy cell leukemia in paraffin-embedded bone marrow trephine biopsies--a tissue microarray study.
Tóth-Lipták J; Piukovics K; Borbényi Z; Demeter J; Bagdi E; Krenács L
Pathol Oncol Res; 2015 Jan; 21(1):203-11. PubMed ID: 24903677
[TBL] [Abstract][Full Text] [Related]
58. TCL1A expression delineates biological and clinical variability in B-cell lymphoma.
Aggarwal M; Villuendas R; Gomez G; Rodriguez-Pinilla SM; Sanchez-Beato M; Alvarez D; Martinez N; Rodriguez A; Castillo ME; Camacho FI; Montes-Moreno S; Garcia-Marco JA; Kimby E; Pisano DG; Piris MA
Mod Pathol; 2009 Feb; 22(2):206-15. PubMed ID: 18820675
[TBL] [Abstract][Full Text] [Related]
59. [Splenic marginal zone lymphoma].
Dimopoulos K; Pedersen M
Ugeskr Laeger; 2012 Oct; 174(40):2383-6. PubMed ID: 23031300
[TBL] [Abstract][Full Text] [Related]
60. Immunohistochemistry for LEF1 and SOX11 adds diagnostic specificity in small B-cell lymphomas.
Rangan A; Reinig E; McPhail ED; Rech KL
Hum Pathol; 2022 Mar; 121():29-35. PubMed ID: 35066013
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
